HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Umayahara, Y. Articles by McCarthy, T. L. Search for Related Content PubMed PubMed Citation Articles by Umayahara, Y. Articles by McCarthy, T. L. Social Bookmarking                      What's this?

Volume 272, Number 50, Issue of December 12, 1997 pp. 31793-31800

CCAAT/Enhancer-binding Protein  Activates Insulin-like Growth Factor-I Gene Transcription in Osteoblasts
IDENTIFICATION OF A NOVEL CYCLIC AMP SIGNALING PATHWAY IN BONE

(Received for publication, August 8, 1997)

Yutaka Umayahara , Changhua Ji ^§ , Michael Centrella ^§ , Peter Rotwein and Thomas L. McCarthy ^§

From the  Oregon Health Sciences University, Department of Medicine, Molecular Medicine Division, Portland, Oregon 97201-3098 and ^§ Yale University School of Medicine, Section of Plastic Surgery, New Haven, Connecticut 06520-8041

Insulin-like growth factor-I (IGF-I) plays a key role in skeletal growth by stimulating bone cell replication and differentiation. We previously showed that prostaglandin E₂ (PGE₂) and other cAMP-activating agents enhanced IGF-I gene transcription in cultured primary rat osteoblasts through promoter 1, the major IGF-I promoter, and identified a short segment of the promoter, termed HS3D, that was essential for hormonal regulation of IGF-I gene expression. We now demonstrate that CCAAT/enhancer-binding protein (C/EBP)  is a major component of a PGE₂-stimulated DNA-protein complex involving HS3D and find that C/EBP transactivates IGF-I promoter 1 through this site. Competition gel shift studies first indicated that a core C/EBP half-site (GCAAT) was required for binding of a labeled HS3D oligomer to osteoblast nuclear proteins. Southwestern blotting and UV-cross-linking studies showed that the HS3D probe recognized a ~ 35-kDa nuclear protein, and antibody supershift assays indicated that C/EBP comprised most of the PGE₂-activated gel-shifted complex. C/EBP was detected by Western immunoblotting in osteoblast nuclear extracts after treatment of cells with PGE₂. An HS3D oligonucleotide competed effectively with a high affinity C/EBP site from the rat albumin gene for binding to osteoblast nuclear proteins. Co-transfection of osteoblast cell cultures with a C/EBP expression plasmid enhanced basal and PGE₂-activated IGF-I promoter 1-luciferase activity but did not stimulate a reporter gene lacking an HS3D site. By contrast, an expression plasmid for the related protein, C/EBP, did not alter basal IGF-I gene activity but did increase the response to PGE₂. In osteoblasts and in COS-7 cells, C/EBP, but not C/EBP, transactivated a reporter gene containing four tandem copies of HS3D fused to a minimal promoter; neither transcription factor stimulated a gene with four copies of an HS3D mutant that was unable to bind osteoblast nuclear proteins. These results identify C/EBP as a hormonally activated inducer of IGF-I gene transcription in osteoblasts and show that the HS3D element within IGF-I promoter 1 is a high affinity binding site for this protein.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Staiger, M. J. Lueben, D. Berrigan, R. Malik, S. N. Perkins, S. D. Hursting, and P. F. Johnson C/EBP{beta} regulates body composition, energy balance-related hormones and tumor growth Carcinogenesis, May 1, 2009; 30(5): 832 - 840. [Abstract] [Full Text] [PDF]

				S. Yakar, C. J. Rosen, M. L. Bouxsein, H. Sun, W. Mejia, Y. Kawashima, Y. Wu, K. Emerton, V. Williams, K. Jepsen, et al. Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism FASEB J, March 1, 2009; 23(3): 709 - 719. [Abstract] [Full Text] [PDF]

				R. Siddappa, A. Martens, J. Doorn, A. Leusink, C. Olivo, R. Licht, L. van Rijn, C. Gaspar, R. Fodde, F. Janssen, et al. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo PNAS, May 20, 2008; 105(20): 7281 - 7286. [Abstract] [Full Text] [PDF]

				T. L. McCarthy, R. B. Hochberg, D. C. Labaree, and M. Centrella 3-Ketosteroid Reductase Activity and Expression by Fetal Rat Osteoblasts J. Biol. Chem., November 23, 2007; 282(47): 34003 - 34012. [Abstract] [Full Text] [PDF]

				T. L. McCarthy, T. H. Pham, B. I. Knoll, and M. Centrella Prostaglandin E2 Increases Transforming Growth Factor-{beta} Type III Receptor Expression through CCAAT Enhancer-Binding Protein {delta} in Osteoblasts Mol. Endocrinol., November 1, 2007; 21(11): 2713 - 2724. [Abstract] [Full Text] [PDF]

				A. S. McLellan, T. Kealey, and K. Langlands An E box in the exon 1 promoter regulates insulin-like growth factor-I expression in differentiating muscle cells Am J Physiol Cell Physiol, August 1, 2006; 291(2): C300 - C307. [Abstract] [Full Text] [PDF]

				C. S. Shin, M. J. Jeon, J.-Y. Yang, S.-J. Her, D. Kim, S. W. Kim, and S. Y. Kim CCAAT/enhancer-binding protein {delta} activates the Runx2-mediated transcription of mouse osteocalcin II promoter. J. Mol. Endocrinol., June 1, 2006; 36(3): 531 - 546. [Abstract] [Full Text] [PDF]

				M. Thangaraju, M. Rudelius, B. Bierie, M. Raffeld, S. Sharan, L. Hennighausen, A-M. Huang, and E. Sterneck C/EBP{delta} is a crucial regulator of pro-apoptotic gene expression during mammary gland involution Development, November 1, 2005; 132(21): 4675 - 4685. [Abstract] [Full Text] [PDF]

				W. Chang, A. Rewari, M. Centrella, and T. L. McCarthy Fos-related Antigen 2 Controls Protein Kinase A-induced CCAAT/Enhancer-binding Protein {beta} Expression in Osteoblasts J. Biol. Chem., October 8, 2004; 279(41): 42438 - 42444. [Abstract] [Full Text] [PDF]

				S. Shimba, T. Wada, S. Hara, and M. Tezuka EPAS1 Promotes Adipose Differentiation in 3T3-L1 Cells J. Biol. Chem., September 24, 2004; 279(39): 40946 - 40953. [Abstract] [Full Text] [PDF]

				M. Centrella, T. L. McCarthy, W.-Z. Chang, D. C. Labaree, and R. B. Hochberg Estren (4-Estren-3{alpha},17{beta}-diol) Is a Prohormone that Regulates Both Androgenic and Estrogenic Transcriptional Effects through the Androgen Receptor Mol. Endocrinol., May 1, 2004; 18(5): 1120 - 1130. [Abstract] [Full Text] [PDF]

				J. Wessells, S. Yakar, and P. F. Johnson Critical Prosurvival Roles for C/EBP{beta} and Insulin-Like Growth Factor I in Macrophage Tumor Cells Mol. Cell. Biol., April 15, 2004; 24(8): 3238 - 3250. [Abstract] [Full Text] [PDF]

				G. E. McCall, D. L. Allen, F. Haddad, and K. M. Baldwin Transcriptional regulation of IGF-I expression in skeletal muscle Am J Physiol Cell Physiol, October 1, 2003; 285(4): C831 - C839. [Abstract] [Full Text] [PDF]

				C. Ji, W. Chang, M. Centrella, and T. L. McCarthy Activation Domains of CCAAT Enhancer Binding Protein {delta}: Regions Required for Native Activity and Prostaglandin E2-Dependent Transactivation of Insulin-Like Growth Factor I Gene Expression in Rat Osteoblasts Mol. Endocrinol., September 1, 2003; 17(9): 1834 - 1843. [Abstract] [Full Text] [PDF]

				Y. Umayahara, Y. Kajimoto, Y. Fujitani, S.-i. Gorogawa, T. Yasuda, A. Kuroda, K. Ohtoshi, S. Yoshida, D. Kawamori, Y. Yamasaki, et al. Protein Kinase C-dependent, CCAAT/Enhancer-binding Protein beta -mediated Expression of Insulin-like Growth Factor I Gene J. Biol. Chem., May 3, 2002; 277(18): 15261 - 15270. [Abstract] [Full Text] [PDF]

				A. M. Delany, D. Durant, and E. Canalis Glucocorticoid Suppression of IGF I Transcription in Osteoblasts Mol. Endocrinol., October 1, 2001; 15(10): 1781 - 1789. [Abstract] [Full Text] [PDF]

				E. N. Kaytor, J. L. Zhu, C.-I Pao, and L. S. Phillips Physiological Concentrations of Insulin Promote Binding of Nuclear Proteins to the Insulin-Like Growth Factor I Gene Endocrinology, March 1, 2001; 142(3): 1041 - 1049. [Abstract] [Full Text] [PDF]

				L. Wang and M. L. Adamo Cell Density Influences Insulin-Like Growth Factor I Gene Expression in a Cell Type-Specific Manner Endocrinology, July 1, 2000; 141(7): 2481 - 2489. [Abstract] [Full Text] [PDF]

				L. Wang, X. Wang, and M. L. Adamo Two Putative GATA Motifs in the Proximal Exon 1 Promoter of the Rat Insulin-Like Growth Factor I Gene Regulate Basal Promoter Activity Endocrinology, March 1, 2000; 141(3): 1118 - 1126. [Abstract] [Full Text] [PDF]

				T. L. McCarthy, C. Ji, Y. Chen, K. Kim, and M. Centrella Time- and Dose-Related Interactions between Glucocorticoid and Cyclic Adenosine 3',5'-Monophosphate on CCAAT/Enhancer-Binding Protein-Dependent Insulin-Like Growth Factor I Expression by Osteoblasts Endocrinology, January 1, 2000; 141(1): 127 - 137. [Abstract] [Full Text] [PDF]

				T. L. McCarthy, Changhua Ji, and M. Centrella Links Among Growth Factors, Hormones, and Nuclear Factors With Essential Roles in Bone Formation Critical Reviews in Oral Biology & Medicine, January 1, 2000; 11(4): 409 - 422. [Abstract] [Full Text] [PDF]

				C. Ji, Y. Chen, T. L. McCarthy, and M. Centrella Cloning the Promoter for Transforming Growth Factor-beta Type III Receptor. BASAL AND CONDITIONAL EXPRESSION IN FETAL RAT OSTEOBLASTS J. Biol. Chem., October 22, 1999; 274(43): 30487 - 30494. [Abstract] [Full Text] [PDF]

				T. Schinke and G. Karsenty Characterization of Osf1, an Osteoblast-specific Transcription Factor Binding to a Critical cis-acting Element in the Mouse Osteocalcin Promoters J. Biol. Chem., October 15, 1999; 274(42): 30182 - 30189. [Abstract] [Full Text] [PDF]

				C. Ji, Y. Chen, M. Centrella, and T. L. McCarthy Activation of the Insulin-Like Growth Factor-Binding Protein-5 Promoter in Osteoblasts by Cooperative E Box, CCAAT Enhancer-Binding Protein, and Nuclear Factor-1 Deoxyribonucleic Acid-Binding Sequences Endocrinology, October 1, 1999; 140(10): 4564 - 4572. [Abstract] [Full Text]

				J.-L. Zhu, C.-I Pao, E. Hunter Jr., K.-w. M. Lin, G.-j. Wu, and L. S. Phillips Identification of Core Sequences Involved in Metabolism-Dependent Nuclear Protein Binding to the Rat Insulin-Like Growth Factor I Gene Endocrinology, October 1, 1999; 140(10): 4761 - 4771. [Abstract] [Full Text]

				J. P. O'Rourke, G. C. Newbound, J. A. Hutt, and J. DeWille CCAAT/Enhancer-binding Protein delta  Regulates Mammary Epithelial Cell G0 Growth Arrest and Apoptosis J. Biol. Chem., June 4, 1999; 274(23): 16582 - 16589. [Abstract] [Full Text] [PDF]

				Y. Umayahara, J. Billiard, C. Ji, M. Centrella, T. L. McCarthy, and P. Rotwein CCAAT/Enhancer-binding Protein delta  Is a Critical Regulator of Insulin-like Growth Factor-I Gene Transcription in Osteoblasts J. Biol. Chem., April 9, 1999; 274(15): 10609 - 10617. [Abstract] [Full Text] [PDF]

				L. M. Grønning, M. K. Dahle, K. A. Taskén, S. Enerbäck, L. Hedin, K. Taskén, and H. K. Knutsen Isoform-Specific Regulation of the CCAAT/Enhancer-Binding Protein Family of Transcription Factors by 3',5'-Cyclic Adenosine Monophosphate in Sertoli Cells Endocrinology, February 1, 1999; 140(2): 835 - 843. [Abstract] [Full Text]

				Y. Kim and S. M. Fischer Transcriptional Regulation of Cyclooxygenase-2 in Mouse Skin Carcinoma Cells. REGULATORY ROLE OF CCAAT/ENHANCER-BINDING PROTEINS IN THE DIFFERENTIAL EXPRESSION OF CYCLOOXYGENASE-2 IN NORMAL AND NEOPLASTIC TISSUES J. Biol. Chem., October 16, 1998; 273(42): 27686 - 27694. [Abstract] [Full Text] [PDF]

				T. L. McCarthy, C. Ji, Y. Chen, K. K. Kim, M. Imagawa, Y. Ito, and M. Centrella Runt Domain Factor (Runx)-dependent Effects on CCAAT/ Enhancer-binding Protein delta Expression and Activity in Osteoblasts J. Biol. Chem., July 7, 2000; 275(28): 21746 - 21753. [Abstract] [Full Text] [PDF]

				G. Elberg, J. M. Gimble, and S. Y. Tsai Modulation of the Murine Peroxisome Proliferator-activated Receptor gamma 2 Promoter Activity by CCAAT/Enhancer-binding Proteins J. Biol. Chem., September 1, 2000; 275(36): 27815 - 27822. [Abstract] [Full Text] [PDF]

				J. Billiard, Y. Umayahara, K. Wiren, M. Centrella, T. L. McCarthy, and P. Rotwein Regulated Nuclear-Cytoplasmic Localization of CCAAT/ Enhancer-binding Protein delta in Osteoblasts J. Biol. Chem., April 27, 2001; 276(18): 15354 - 15361. [Abstract] [Full Text] [PDF]

				J. Billiard, S. S. Grewal, L. Lukaesko, P. J. S. Stork, and P. Rotwein Hormonal Control of Insulin-like Growth Factor I Gene Transcription in Human Osteoblasts. DUAL ACTIONS OF cAMP-DEPENDENT PROTEIN KINASE ON CCAAT/ENHANCER-BINDING PROTEIN delta J. Biol. Chem., August 10, 2001; 276(33): 31238 - 31246. [Abstract] [Full Text] [PDF]

				S. Gutierrez, A. Javed, D. K. Tennant, M. van Rees, M. Montecino, G. S. Stein, J. L. Stein, and J. B. Lian CCAAT/Enhancer-binding Proteins (C/EBP) beta and delta Activate Osteocalcin Gene Transcription and Synergize with Runx2 at the C/EBP Element to Regulate Bone-specific Expression J. Biol. Chem., January 4, 2002; 277(2): 1316 - 1323. [Abstract] [Full Text] [PDF]